Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MAC-MOD Analytical Avantor ACE Excel - Bioanalytical Oligo, 90 A, 1.7 um, 2.1 x 100 mm UHPLC Column
SDP

Supplier:  MAC-MOD Analytical EXL17151002

Encompass_Preferred

There are 2 phases in the Avantor ACE Excel-Bioanalytical line, the ACE Oligo and ACE Glycan. The Oligo stationary phase is chemically modified to withstand an extended pH range. Several impurities can be produced during oligonucleotide synthesis (e.g. failure sequences) which need to be separated from the desired product. Ion-pair RPLC can be employed for the analysis of trityl-off deprotected oligonucleotides. Triethylammonium acetate (TEAA) can be used to ion pair with the negatively charged phosphodiester backbone of the oligonucleotide. The ACE Glycan is a hydrophilic stationary phase which is ideal for glycan analysis due to their highly polar nature. Labelling with a fluorophore such as 2-aminobenzamide (2-AB) allows the released glycans to be analyzed using fluorescence detection. Both columns are available in analytical sizes and in 1.7 micron and 3 micron particle size formats. Note: Guard Columns are available and require guard holder H0011.

Catalog No. 50-237-0060


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.